Vertex Pharmaceuticals Non-Employee Director Compensation Policy

Summary

This document outlines the compensation policy for non-employee members of the Vertex Pharmaceuticals Board of Directors. It specifies annual retainers, meeting fees for both in-person and telephonic participation, additional compensation for committee chairs, and details on equity grants awarded upon joining the board and annually thereafter. The policy also provides extra equity grants for the independent Chairman or Lead Independent Director. The agreement ensures clear, structured compensation for board service, including both cash payments and stock options, with vesting schedules and eligibility criteria.

EX-10.50 3 a2201820zex-10_50.htm EX-10.50

Exhibit 10.50

 

Vertex Pharmaceuticals Non-Employee Board Compensation

 

Annual Retainer:

$25,000

 

 

Board Meeting Fees

 

In-Person Board Meetings

$2,500

Telephonic Board Meetings

$1,250 (none for meetings called for less than 30 minutes)

 

 

Committee Meeting Fees

 

In-Person on Regular Board Meeting Day

$500

In-Person Meeting held on Day other than regular

$1,000

Board Meeting Day

 

Telephone Meeting

$375

 

 

Committee Chair Compensation

 

 

 

Audit & Finance Chair

$20,000 annual retainer

 

 

Corporate Governance & Nominating

$20,000 annual retainer

Committee Chair

 

 

 

Management Development & Compensation Committee

$14,000 annual retainer

Chair

 

 

 

Equity Grants

Upon first election to the Board, 30,000 options, vesting quarterly over four years; and

 

On June 1 of each year in service, 20,000 fully vested options

 

On June 1 of each year, 2,500 fully vested options for the Chairman of the Board, if independent, or the Lead Independent Director.